139 related articles for article (PubMed ID: 38326125)
1. Impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer: A multicenter randomized clinical trial protocol (FRAGINOC).
Daviu Cobián C; Oreskov JO; Blaakaer J; Jespersen E; Jørgensen TL; Ryg J; Herrstedt J; Høgdall C; Lund CM; Seibæk L; Vinther A; Ekmann-Gade AW; Schnack TH
J Geriatr Oncol; 2024 Apr; 15(3):101713. PubMed ID: 38326125
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of geriatric oncology screening and geriatric assessment of older patients with cancer: A randomized clinical trial protocol (PROGNOSIS-RCT).
Giger AW; Ditzel HM; Jørgensen TL; Ditzel HJ; Mohammadnejad A; Ewertz M; Pfeiffer P; Lund CM; Ryg J
J Geriatr Oncol; 2022 Jan; 13(1):116-123. PubMed ID: 34362713
[TBL] [Abstract][Full Text] [Related]
3. Effects of comprehensive geriatric assessment-guided interventions on physical performance and quality of life in older patients with advanced cancer: A randomized controlled trial (PROGNOSIS-RCT).
Giger AW; Ditzel HM; Ditzel HJ; Ewertz M; Jørgensen TL; Pfeiffer P; Lund CM; Ryg J
J Geriatr Oncol; 2024 Jan; 15(1):101658. PubMed ID: 37939628
[TBL] [Abstract][Full Text] [Related]
4. Protocol for a randomised controlled trial on impact of comprehensive geriatric and supportive assessment versus standard care in older adults with cancer undergoing curative treatment: The Geriatric Oncology SuPportive clinic for ELderly (GOSPEL) study.
Goh WY; Neo HY; Teo HL; Koh MYH; Griva K; Lim MY; Ho FCH; Hum AYM
J Geriatr Oncol; 2023 Jan; 14(1):101342. PubMed ID: 35843845
[TBL] [Abstract][Full Text] [Related]
5. Geriatric assessment and intervention in older vulnerable patients undergoing surgery for colorectal cancer: a protocol for a randomised controlled trial (GEPOC trial).
Dolin TG; Mikkelsen M; Jakobsen HL; Nordentoft T; Pedersen TS; Vinther A; Zerahn B; Vistisen KK; Suetta C; Nielsen D; Johansen JS; Lund CM
BMC Geriatr; 2021 Jan; 21(1):88. PubMed ID: 33516195
[TBL] [Abstract][Full Text] [Related]
6. GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.
van Soolingen NJ; Smorenburg CH; Hamaker ME; Groen WG; Retèl VP; Lok CAR; van de Poll-Franse LV; Trum JW
Trials; 2020 Feb; 21(1):214. PubMed ID: 32087750
[TBL] [Abstract][Full Text] [Related]
7. Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
Jiang R; Zhu J; Kim JW; Liu J; Kato K; Kim HS; Zhang Y; Zhang P; Zhu T; Aoki D; Yu A; Chen X; Wang X; Zhu D; Zhang W; Jia H; Shi T; Gao W; Yin S; Feng Y; Xiang L; Okamoto A; Zang R
J Gynecol Oncol; 2020 Sep; 31(5):e86. PubMed ID: 32808504
[TBL] [Abstract][Full Text] [Related]
8. Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer-the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial.
Normann M; Ekerstad N; Angenete E; Prytz M
Trials; 2022 Nov; 23(1):948. PubMed ID: 36397083
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.
Logan B; Viecelli AK; Johnson DW; Aquino EM; Bailey J; Comans TA; Gray LC; Hawley CM; Hickey LE; Janda M; Jaure A; Jose MD; Kalaw E; Kiriwandeniya C; Matsuyama M; Mihala G; Nguyen KH; Pascoe E; Pole JD; Polkinghorne KR; Pond D; Raj R; Reidlinger DM; Scholes-Robertson N; Varghese J; Wong G; Hubbard RE;
Trials; 2023 May; 24(1):365. PubMed ID: 37254217
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A
BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271
[TBL] [Abstract][Full Text] [Related]
13. Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy.
Zhang Y; Grant MS; Zhang X; Paraghamian SE; Tan X; Clark LH
J Minim Invasive Gynecol; 2021 Jun; 28(6):1237-1243. PubMed ID: 33248314
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
[No Abstract] [Full Text] [Related]
15. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD005343. PubMed ID: 34328210
[TBL] [Abstract][Full Text] [Related]
17. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
18. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Fagotti A; Ferrandina G; Vizzielli G; Fanfani F; Gallotta V; Chiantera V; Costantini B; Margariti PA; Gueli Alletti S; Cosentino F; Tortorella L; Scambia G
Eur J Cancer; 2016 May; 59():22-33. PubMed ID: 26998845
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
